Shanghai Pharmaceuticals Holding Co., Ltd

シンボルマーク: SHPMY

PNK

7.41

USD

今日の市場価格

51.8164
PER（株価収益率
0.1005
PEGレシオ
7.20B
MRK キャップ
0.01%
DIV利回り

Shanghai Pharmaceuticals Holding Co., Ltd (SHPMY) 財務諸表

Q: Shanghai Pharmaceuticals Holding Co., LtdSHPMY 総資産とは何ですか？

Shanghai Pharmaceuticals Holding Co., Ltd (SHPMY) 総資産は .

Q: 企業のフリーキャッシュフローとは？

フリーキャッシュフローは .

Download

年次四半期

リニア対数

チャート上ではのダイナミクスにおけるデフォルトの数値を見ることができる。Shanghai Pharmaceuticals Holding Co., Ltd (SHPMY). 会社の収益は NaN M の平均を示し、これは NaN % の成長率です。全期間の平均売上総利益は NaN M であり、NaN % である。平均売上総利益率は NaN % である。昨年度の純利益成長率はNaN % で, NaN % % に等しい。に等しい.,

年次四半期

10Y 20Y 30Y 40Y

貸借対照表

Shanghai Pharmaceuticals Holding Co., Ltdの財政の軌跡に飛び込むと、平均的な資産の伸びが観察される。この率は、興味深いことに、であり、会社の最高と最低の両方を反映している。前期比で比較すると、この数字はに調整される。過去1年間を振り返ってみると、総資産の変動は NaN となる. 総株主資本によって示される株主価値は、報告通貨でのNaN で評価される。この面の前年比変化はNaN% である.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994
balance-sheet.row.cash-and-short-term-investments	40669.9	37015	22390.4	22296.2	18152.8	18694.7	14842.7	11970.9	12039.8	11608.6	12978.8	13528.3	14852.7	6341.6	1229.2	1046.4	665.2	564	430.1	522.7	555.3	675.2	587.3	699.2	435.7	258.9	63.2	36.2	30.6	0
balance-sheet.row.short-term-investments	11197.2	9613.6	-1242.8	-1226.3	-1362.9	-1434.9	0.6	4.1	0.8	0.5	0.3	2.9	2.7	3.2	7.3	9.2	35.8	62.5	115.9	92.3	43.1	3.1	50.6	100	0.7	0	0	0	0	0
balance-sheet.row.net-receivables	81003.7	76634	65885.8	59921.7	53944.4	48324.7	35415.5	30982.1	27895.5	23605.7	18170.1	15008.5	12701.1	9322.2	3419.6	2853.3	2751.2	2582.3	2539.6	3002.4	2474.6	1923.1	1615.8	53.1	98.9	92.1	30.2	13.7	19.7	0
balance-sheet.row.inventory	36623.4	34460.2	27104	24088.3	24877.4	25024	17270	16415.8	15090.6	13088.2	10996.5	9809.7	8297.5	5040.7	1974.5	1622.8	1364.2	1191.4	1351.1	1223	1370.2	1170	824	610.9	571.3	608.5	125.3	99	73	0
balance-sheet.row.other-current-assets	4136.9	1403.7	1114.2	1256.7	1117	1234.5	1114.1	898.2	559.3	355.9	369.6	455.4	144.5	2.7	-121.4	0.1	0.1	15.3	21.5	2.5	0	0	0.3	1329.2	1201.6	1068.6	120.2	95.5	86.4	189.1
balance-sheet.row.total-current-assets	162433.9	149512.9	116494.4	107562.9	98091.6	93277.9	68642.3	60266.9	55585.2	48658.3	42515	38801.9	35995.8	20707.2	6502	5522.6	4780.7	4353	4342.2	4750.5	4400.2	3768.3	3027.5	2692.4	2307.5	2028	339	244.4	209.7	189.1
balance-sheet.row.property-plant-equipment-net	18278.7	16185.3	15390.7	14220.6	12717.7	10194.6	8691.6	6561.1	5693.4	4993.7	4808.9	4259.4	4039.6	3978.5	892.4	913.5	1129.5	1184.6	979.6	1033.1	1077.1	1058.1	698.4	577.2	511.2	420	217.7	223.6	203	222.3
balance-sheet.row.goodwill	11393.3	11335.9	11239	11342.3	10789.9	11345.3	6606.7	5848	4815.6	4473.4	3643.3	3172.8	2988.9	422.8	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	6361.3	6586.7	6308.7	5419.1	4142	4283.2	2702.4	2767.1	1984.2	1861.6	1540.3	1406.7	1276.2	875.9	432.5	446.6	526.2	366.1	73.7	143.9	186.1	195.5	183.7	84.7	91.1	96.7	0.3	0.3	0.3	0
balance-sheet.row.goodwill-and-intangible-assets	17754.7	17922.7	17547.6	16761.3	14931.9	15628.5	9309.1	8615.1	6799.8	6335	5183.6	4579.5	4265.1	1298.7	432.5	446.6	526.2	366.1	73.7	146.9	186.1	195.5	183.7	84.7	91.1	96.7	0.3	0.3	0.3	0
balance-sheet.row.long-term-investments	11145.3	1863.6	11778.3	8888.9	6795.3	6083.4	4802.6	4492.5	3914.6	2932.5	2845.9	2691.4	2634.7	1597.4	277.7	330.2	299.6	701.1	846.5	393.5	404.8	330.4	295.6	36.6	125.2	0	0	0	0	0
balance-sheet.row.tax-assets	1716.9	1534.7	1367.5	1359.4	1222.5	1037.9	566.3	468.3	316.3	264.6	199.8	191.7	178.6	150.2	80.3	47.4	29.1	0	0	0	86.6	50.6	88	3.1	-111.6	0	0	0	0	0
balance-sheet.row.other-non-current-assets	643.1	11115.7	856.9	392.5	3267.5	657.1	2332.6	2338.8	2035	1156.4	758.3	544.9	554	437	944.1	990.4	720.9	73.7	134.1	140.1	86.6	50.6	88	144.4	20.7	66.5	35.6	33.8	36.8	10.3
balance-sheet.row.total-non-current-assets	49538.7	48622	46941.1	41622.7	38934.8	33601.5	25702.2	22475.8	18759	15682.2	13796.5	12267.1	11672	7461.8	2155	2232.9	2344.9	2325.5	2033.8	1713.6	1754.7	1634.5	1265.7	842.9	748.2	583.2	253.6	257.6	240.2	232.6
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	211972.5	198134.9	163435.5	149185.7	137026.4	126879.3	94344.5	82742.7	74344.2	64340.6	56311.5	51069	47667.8	28169	8657	7755.5	7125.6	6678.6	6376.1	6464.2	6154.8	5402.8	4293.1	3535.3	3055.6	2611.2	592.5	502.1	449.8	421.8
balance-sheet.row.account-payables	47915	51565.5	41995.4	37792.2	36872.5	35148	27295.2	25985.1	24436.9	20435.9	16875.8	14574.9	12659.5	8667.7	3974.2	3096	2689.7	2061.8	1650.6	1823.1	1534.1	1377.1	965.8	687.8	698.9	718.7	62.2	56.8	36.6	0
balance-sheet.row.short-term-debt	51217.4	31000	23096.6	29107.2	24327.3	22038.7	13803.5	9646.7	10679.3	7953.1	5924.4	4900.8	5675.5	4818.4	1691.1	1919.5	1999.5	2148.3	2309.9	2057.2	1897.7	1511	1131.2	1578	1308.8	984	195.8	188.3	103.1	0
balance-sheet.row.tax-payables	809.8	1440.8	1692.7	1478.1	1215.4	1042.2	1141.4	642.5	612	546.5	393.6	415.9	393.1	254.3	56.8	29	-0.4	19.3	-49.8	-22.7	-16.1	-14.5	6.2	-4.5	-5.7	-10.8	11.5	3.9	0.4	0
balance-sheet.row.long-term-debt-total	5786.2	7561.4	8592	2685.1	10289.9	9620.3	2958.8	2836.3	93.4	105.4	125.2	40.8	52.3	66.1	22.1	25.1	3	1.2	103.2	102.1	89.7	30.8	17.5	2.6	1.6	15.6	21.5	33.7	100.7	0
Deferred Revenue Non Current	67.4	534.6	2349.1	2224.1	1278.7	503.3	495.8	589.7	367.9	554.3	0.5	0.5	160.4	156.9	28.1	30.4	32.3	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	21268.8	6384.9	9232.4	5018.6	1188.6	2698.4	8533.1	5481.5	4310.4	3613.5	2898.7	2622.4	2521	2431.5	592.8	566.1	437.4	377.7	283.1	392.4	463	444.3	316.3	293.5	196.8	172.8	27.4	34.2	26.4	130.9
balance-sheet.row.total-non-current-liabilities	8708.5	9441.4	12545	6311.9	13032.8	11736.3	5036.8	4794.9	1109.6	1238.9	1611.6	1270.1	830.4	367.2	76.4	84.1	40.8	23.8	126.6	130.4	132.6	70.8	61.6	-9.3	1.2	22.3	21.5	33.7	100.7	94.3
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	1550.1	1301.6	1434.3	1501	1155.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	131080.4	120132.5	104369.3	94444.9	87640.5	80446.1	54668.6	45908.3	40536.2	33241.4	27310.5	23368.2	21686.4	16284.8	6334.6	5665.8	5167.3	4611.7	4370.2	4403.1	4027.4	3403.2	2474.9	2550	2205.7	1897.8	306.9	313	266.9	225.2
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	3703.3	3697.5	2842.1	2842.1	2842.1	2842.1	2688.9	2688.9	2688.9	2688.9	2688.9	2688.9	2688.9	1992.6	569.2	569.2	569.2	474.3	474.3	474.3	474.3	316.2	316.2	229.6	229.6	153	113	58	58	58
balance-sheet.row.retained-earnings	33822.3	32479.9	28598.6	25054.4	21970.9	19330.6	16578.3	14138.4	11961	10009.3	8252.6	6718.3	5196.3	3117	437.3	304.1	263	301.1	279	286.7	282.1	168.9	154.9	123.3	32.5	64.9	17.3	0.1	0	16.5
balance-sheet.row.accumulated-other-comprehensive-income-loss	1532.1	1553.9	1565.1	1152.1	531.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	29466.4	29331.7	16353.7	16306.2	16315	16840.8	14763.6	14795.2	15280.4	15123.9	15012.3	15232.1	15193.3	4024.9	827.1	815.8	809.2	980	1004.3	1002.2	973.4	1074.5	1034.2	441.2	365.8	380.1	155.2	131	125	122.2
balance-sheet.row.total-stockholders-equity	68524.1	67063	49359.5	45354.7	41659.1	39013.6	34030.8	31622.6	29930.3	27822.1	25953.8	24639.3	23078.5	9134.6	1833.5	1689.1	1641.4	1755.5	1757.6	1763.3	1729.8	1559.6	1505.3	794	627.8	598	285.6	189.1	183	196.6
balance-sheet.row.total-liabilities-and-stockholders-equity	211972.5	198134.9	163435.5	149185.7	137026.4	126879.3	94344.5	82742.7	74344.2	64340.6	56311.5	51069	47667.8	28169	8657	7755.5	7125.6	6678.6	6376.1	6464.2	6154.8	5402.8	4293.1	3535.3	3055.6	2611.2	592.5	502.1	449.8	421.8
balance-sheet.row.minority-interest	11801.9	10939.4	9706.7	9386.1	7726.9	7419.7	5645	5211.9	3877.7	3277	3047.2	3061.6	2903	2749.7	488.9	400.7	316.9	311.5	248.3	297.8	397.7	440	312.9	191.3	222.1	115.5	0	0	0	0
balance-sheet.row.total-equity	80326.1	78002.5	59066.2	54740.7	49385.9	46433.3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	22342.5	11477.2	10535.6	7662.7	5432.4	4648.6	4803.2	4496.6	3915.4	2933	2846.2	2694.4	2637.3	1600.6	285	339.3	335.5	763.6	962.4	485.8	448	333.5	346.2	136.6	125.9	55.6	0.4	0.4	0.9	0
balance-sheet.row.total-debt	58553.6	38561.4	31688.6	31792.3	34617.1	31659	16762.3	12483	10772.7	8058.5	6049.6	4941.5	5727.8	4884.5	1713.2	1944.6	2002.4	2149.6	2413.2	2159.3	1987.3	1541.9	1148.6	1580.5	1310.4	999.6	217.3	222	203.8	0
balance-sheet.row.net-debt	29080.9	11160	9298.3	9496.1	16464.3	12964.3	1920.2	516.2	-1266.3	-3549.5	-6928.9	-8583.9	-9122.3	-1453.9	491.3	907.4	1373	1648.1	2099	1728.9	1475.1	869.8	611.9	981.3	875.4	740.7	154.2	185.8	173.2	0

キャッシュフロー計算書

Shanghai Pharmaceuticals Holding Co., Ltd の財務状況は、直近の期間においてフリー・キャッシュ・フローに顕著な変化が見られ、NaN の推移を示している。同社は最近、NaN を発行して株式資本を拡大し、前年度と比較してNaN の差を示した. 当社の投資活動は、報告通貨で NaN に相当する正味現金使用量をもたらしました。これは、NaN の前年からのシフトです. 同時期に、同社は NaN, NaN、および NaN を記録しており、同社の投資および返済戦略を理解する上で重要です. 財務活動によるキャッシュ・フローはNaN となり、前年同期との差はNaN となった。また、NaN を株主への配当に充当した。同時に、NaN と呼ばれるその他の財務操作も行っており、これらもこの期間のキャッシュフローに大きな影響を与えた. これらの要素を総合すると、会社の財務状況とキャッシュフロー管理に対する戦略的アプローチの包括的な絵が描かれる。

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998
cash-flows.row.net-income	3768	6992	6274.6	5605.3	4830.7	4456.3	4057.8	3829.7	3364.4	2992	2626.6	2460.6	2446	1779	263.5	129.4	95.5	90.5	71.4	138.5	207.5	163.1	174.8	204.7	110.8	89.8
cash-flows.row.depreciation-and-amortization	2361.2	2222.4	2139.8	2137.8	1885	1169.5	840	746.1	672.6	585	549.7	536.6	479.2	382.7	93.2	94.2	96.4	69.1	59.1	74.2	70.3	72.3	50.4	50.1	43.4	21.4
cash-flows.row.deferred-income-tax	-194.8	-131.9	165	-233.9	-217.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	-8873.1	131.9	-165	233.9	217.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-4150.7	-4680	-3398.7	-2013.7	-2571	-3711.7	-2291.7	-2635.8	-2747.8	-2234.2	-2275.2	-2026.7	-942.8	-368.4	62.9	-104	109.2	298.3	-148.2	-242.3	-230.7	-231	-171.1	-101.2	-61.8	-464.7
cash-flows.row.account-receivables	-6432.4	-10081.4	-6155.5	-4072.2	-5083.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	-2303.8	-7111.7	-3201	932.6	63.1	-2842.9	-423	-942.7	-1943.7	-1587	-1179.7	-1466.4	-1565.9	-859.2	-323.3	-270.1	-12.3	153.4	-158.7	71.3	-300	-209.9	-206.2	-39.7	75.8	-509.9
cash-flows.row.account-payables	4585.5	12645	5792.8	1359.7	2667.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	0	-131.9	165	-233.9	-217.7	-868.8	-1868.8	-1693.1	-804.2	-647.3	-1095.4	-560.3	623.1	490.8	386.2	166.1	121.5	144.9	10.5	-313.6	69.3	-21.1	35.1	-61.5	-137.6	45.1
cash-flows.row.other-non-cash-items	13303.7	208.9	45.6	1115.4	1877.7	1221.1	42.8	6.7	60.1	-7.1	72.3	180.3	-210	-107.2	244.6	166.1	187.8	125.1	90.7	91.2	-46.6	96.5	11.7	-7.4	72.2	70.4
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-2970.6	-2684.9	-4118.8	-3010	-2753.1	-1943	-2007.3	-2119.3	-1720.5	-1291.5	-905.1	-708.9	-413.5	-550.3	-80	-90.5	-192.3	-151.6	-198.1	-254.4	-169.6	-279.4	-144.7	-141.1	-52.5	-169.9
cash-flows.row.acquisitions-net	-1162	22.5	-1039.3	-2045.7	-693.7	-5197.5	-913.6	-1738.7	-602.7	-1083.2	-455.3	-414.2	-4017.5	-2001.5	4	111.2	20.7	218.2	270.2	341.7	176.7	56.5	157.5	142.3	0.2	0
cash-flows.row.purchases-of-investments	-28423.1	-39683.8	-3147.8	-4490.9	-1041.4	-1047.6	-4461.3	-2600.6	-1887.9	-707.9	35.8	20.1	41.6	-1325.4	-6.3	-23.2	-13	-22.6	-159.4	-190.1	-344.6	-78.7	-405	-102.3	-175.8	-31.2
cash-flows.row.sales-maturities-of-investments	27986.8	30267	3288.2	4806.1	1271.6	1331.8	5119.4	3099.4	2055.4	976.9	251	179.6	476.3	430.4	36.3	62.1	22.5	108.9	10.3	122.9	102.5	75.4	334.2	122.2	2.1	4.9
cash-flows.row.other-investing-activites	1270.7	-394	-997.8	3034.8	-1367.7	-836.4	-92.2	469.7	246.6	261.1	216.5	542.3	164.3	703.8	3.9	290.2	9.2	66.6	72.1	87.3	7.1	182.9	12.8	1.2	0.3	-0.1
cash-flows.row.net-cash-used-for-investing-activites	-3298.2	-12473.1	-6015.6	-1705.7	-4584.3	-7692.7	-2355	-2889.5	-1908.9	-1844.6	-892.8	-401.3	-3790.4	-2743	-46.1	349.8	-173.6	1.3	-275	-234.2	-404.6	-99.8	-202.7	-120	-225.8	-196.2
cash-flows.row.debt-repayment	-6855	-59808.7	-52214.6	-47575.5	-38340.3	-53206.6	-22044.2	-18181.3	-18367.5	-13253.9	-10475.4	-8897.8	-12753.3	-5212.4	-3352.6	-3656.8	-3091.2	-4245.5	-3786.5	-3967.5	-204.2	-289.3	-2536.2	-1871.5	-1822.2	-1445.9
cash-flows.row.common-stock-issued	0	0	0	0	0	2624.8	21.8	905.6	301.4	17.2	35.5	55.1	0	2046.4	6.9	24.3	0	0	0	7.2	0.9	4.5	606.4	0	0	263.2
cash-flows.row.common-stock-repurchased	0	0	0	0	0	60659.6	25613.7	18697.4	19978.7	14169.7	11301.7	7764.4	0	4038.1	3061.5	3581.5	0	0	0	4170.7	595	537.4	1427.5	0	0	1703.9
cash-flows.row.dividends-paid	-2259	-3093.9	-2675.9	-2418.4	-2584.2	-2357.8	-1750.2	-1443.5	-1378.2	-1251.6	-1055.4	-891.2	-775.3	-545.6	-136.7	-196	-141.8	-139.2	-210.2	-128.4	-148.3	-122.9	-49.7	-126.5	-50.4	-73
cash-flows.row.other-financing-activites	-4540.6	75041.2	56456.1	48732.6	38598.7	-193.7	26087.3	19366.6	20080.6	13539.5	10773.8	7707.9	24171.7	6037.1	3092.2	3556.4	2897.7	3985.6	4084.9	4177.8	595.9	541.9	2053.9	2135.9	2110.2	1935.8
cash-flows.row.net-cash-used-provided-by-financing-activities	55.4	12138.6	1565.6	-1261.2	-2325.8	7526.3	2314.7	647.4	636.4	-948.8	-721.6	-2026	10643.1	2325.4	-390.3	-272.1	-335.3	-399.1	88.3	89.1	244.3	134.2	74.5	137.9	237.5	680
cash-flows.row.effect-of-forex-changes-on-cash	-5.6	-12.4	-50.3	-17.6	-1.6	67.4	-18.8	-2.6	10.7	2.8	-14.6	22.7	-280.8	-5.5	0.5	1.4	-1.5	2	-2.5	1.7	0	0	0	0	-0.2	0
cash-flows.row.net-change-in-cash	3152.7	4396.4	561.1	3860.2	-889.3	3036.1	2589.7	-298.1	87.4	-1454.9	-655.5	-1253.8	8344.3	1263.1	228.2	364.9	-21.5	187.3	-116.2	-81.7	-159.9	135.3	-62.5	164.2	176.1	200.6
cash-flows.row.cash-at-end-of-period	29472.7	24533.9	20137.5	19576.4	15716.3	16605.6	13569.4	10979.7	11277.9	11190.4	12645.4	13300.9	14554.7	6039.6	1197.7	969.5	607.2	501.5	314.2	430.5	512.2	672.1	536.8	599.2	435	258.9
cash-flows.row.cash-at-beginning-of-period	26320.1	20137.5	19576.4	15716.3	16605.6	13569.4	10979.7	11277.9	11190.4	12645.4	13300.9	14554.7	6210.4	4776.5	969.5	604.7	628.7	314.2	430.5	512.2	672.1	536.8	599.2	435	258.9	58.2
cash-flows.row.operating-cash-flow	6214.3	4743.4	5061.3	6844.7	6022.4	3135.1	2648.8	1946.7	1349.2	1335.7	973.4	1150.8	1772.4	1686.1	664.1	285.7	488.9	583.1	73	61.7	0.5	100.8	65.7	146.2	164.7	-283.1
cash-flows.row.capital-expenditure	-2970.6	-2684.9	-4118.8	-3010	-2753.1	-1943	-2007.3	-2119.3	-1720.5	-1291.5	-905.1	-708.9	-413.5	-550.3	-80	-90.5	-192.3	-151.6	-198.1	-254.4	-169.6	-279.4	-144.7	-141.1	-52.5	-169.9
cash-flows.row.free-cash-flow	3243.7	2058.5	942.6	3834.7	3269.3	1192.1	641.5	-172.6	-371.3	44.2	68.4	441.9	1358.9	1135.8	584.2	195.2	296.7	431.5	-125.1	-192.7	-169.1	-178.6	-79	5.1	112.2	-453

損益計算書の行

Shanghai Pharmaceuticals Holding Co., Ltd の売上は前期比 NaN% の変化。SHPMY の売上総利益は NaN と報告されている。同社の営業費用は NaN で、前期比NaN% の変化を示している. 減価償却費は NaN であり、前期からの増減率は NaN% である。営業費用は NaN と報告されており、前年比NaN% の変化を示している。販売・マーケティング費用は NaN で、前年度比 NaN% の変化である。直近の数字に基づくEBITDAは NaN で、前年比NaN% の伸びを示す。営業利益は NaN で、前年度比NaN% の変化を示している。当期純利益の増減率は NaN%。前年度の当期純利益は NaN であった。

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994
income-statement-row.row.total-revenue	259557	231981.3	215824.3	191909.2	186565.8	159084.4	130847.2	120764.7	105516.6	92398.9	78222.8	68078.1	54899.9	37411.1	19568.1	16547.8	13919.8	11410.3	10699.3	10815	9785.8	7235.7	5202	4595.3	4529.9	4413.4	339.8	321	337.4	241.3	225.7
income-statement-row.row.cost-of-revenue	230524.4	201494.9	187281.1	164474	159751.7	136521.5	114122.7	106530.9	92715.3	80994.1	67980.1	58792.6	46882.2	30619.9	17851.8	15101.4	12697.8	10618.3	9997.3	9794	8774.9	6215.3	4491.7	4003.8	3970	3886.7	291.8	270.4	291.9	205.8	193.8
income-statement-row.row.gross-profit	29032.6	30486.4	28543.1	27435.2	26814.1	22562.9	16724.5	14233.8	12801.3	11404.8	10242.7	9285.5	8017.7	6791.1	1716.3	1446.4	1222	792	702	1020.9	1010.9	1020.3	710.3	591.5	559.9	526.7	48	50.6	45.5	35.4	31.9
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-310	12.4	-267.7	117.6	174.1	144.3	-23.3	484.6	522.9	547.9	185.2	271.6	187.7	183.6	-12.3	39.8	25.2	43.9	61	69.6	55.1	36.6	7.6	9.3	9.6	22	22.7	-0.3	0.4	1.4	0.7
income-statement-row.row.operating-expenses	20837.5	21705.4	20616.2	19297.4	18884.5	16326.3	11747	9972.3	8846.1	8010.4	7341	6617.6	5584.3	4909.4	1112.4	1095.3	956.4	630	632	925.2	850.3	843.1	544.3	413.1	379.3	380.5	20.4	20.8	15.6	9.1	6.6
income-statement-row.row.cost-and-expenses	251361.9	223200.3	207897.3	183771.4	178636.2	152847.7	125869.7	116503.2	101561.4	89004.5	75321.1	65410.2	52466.5	35529.4	18964.2	16196.7	13654.2	11248.2	10629.3	10719.2	9625.1	7058.5	5036	4416.9	4349.3	4267.2	312.2	291.2	307.5	214.9	200.4
income-statement-row.row.interest-income	-461.8	438.3	338.2	288.3	234	197.4	161.4	172	138	207	242.1	304.4	262.9	47.2	10.6	8.4	20.8	18.5	19.7	23.4	15.5	7.8	8.2	17.6	0	0	0	0	0	0	0
income-statement-row.row.interest-expense	1885	1689.3	1518.2	1411.9	1405.2	1204.4	875.7	645.1	613.3	584.9	413.7	472.4	461.8	213.5	113.2	156.5	141.7	127.3	47.8	36.4	52.1	30.6	13.4	55	48.3	63.7	20.9	12	8.9	3.9	2.9
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-1270.2	-206.3	-61.7	-8.9	48.5	135	-23.3	431.9	485.2	530.2	186.5	291.8	161.4	96	-15.8	23.1	23.9	16.9	37.5	40.7	38.4	21.9	-1	3.8	0.4	19.6	-1	-0.2	0.2	1.2	-0.2
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-310	12.4	-267.7	117.6	174.1	144.3	-23.3	484.6	522.9	547.9	185.2	271.6	187.7	183.6	-12.3	39.8	25.2	43.9	61	69.6	55.1	36.6	7.6	9.3	9.6	22	22.7	-0.3	0.4	1.4	0.7
income-statement-row.row.total-operating-expenses	-1270.2	-206.3	-61.7	-8.9	48.5	135	-23.3	431.9	485.2	530.2	186.5	291.8	161.4	96	-15.8	23.1	23.9	16.9	37.5	40.7	38.4	21.9	-1	3.8	0.4	19.6	-1	-0.2	0.2	1.2	-0.2
income-statement-row.row.interest-expense	1885	1689.3	1518.2	1411.9	1405.2	1204.4	875.7	645.1	613.3	584.9	413.7	472.4	461.8	213.5	113.2	156.5	141.7	127.3	47.8	36.4	52.1	30.6	13.4	55	48.3	63.7	20.9	12	8.9	3.9	2.9
income-statement-row.row.depreciation-and-amortization	2361.2	2222.4	2139.8	2137.8	1885	1169.5	840	746.1	672.6	585	549.7	536.6	479.2	382.7	93.2	94.2	96.4	69.1	59.1	74.2	70.3	72.3	50.4	50.1	43.4	21.4	-3	11.7	8.5	3.3	1.6
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	8195.1	9014.7	8205.5	7184.4	6213.9	5208.3	5228.2	4207.1	3686.6	3269.5	3074.3	2795.9	2873.7	2076.6	370.7	163.6	122.6	84.6	61.2	150.1	219.5	191.6	203.3	218.4	137.5	89.9	30.6	18.1	21.4	23	23.7
income-statement-row.row.income-before-tax	6925	8808.4	8143.8	7175.5	6262.5	5343.4	5204.8	4639	4171.9	3799.7	3260.8	3087.7	3035.1	2172.5	355	186.7	146.6	101.5	98.7	190.8	257.9	213.5	202.3	222.3	137.9	109.6	29.7	17.9	21.6	24.2	23.4
income-statement-row.row.income-tax-expense	1887.7	1816.3	1869.2	1570.2	1431.7	887.1	1147	809.3	807.5	807.7	634.2	627.1	589.1	393.6	91.5	57.3	51.1	40.3	25.9	52.3	50.4	50.3	27.6	17.6	27.1	19.8	1	2.6	3.2	3.6	3.6
income-statement-row.row.net-income	3768	5617.2	5093.5	4496.2	4081	3881.1	3520.6	3196.4	2877	2591.1	2242.9	2052.9	2042.2	1368.3	173.3	82	66.3	68.7	50.5	93.1	154.4	125.8	145.3	184.8	94.4	78.7	28.7	15.2	18.3	20.6	19.9